ConductScience.org, home

Paper718156

Comparative susceptibilities of anaerobic bacteria to metronidazole, ornidazole, and SC-28538.

Goldstein EJ and 2 others. Antimicrob Agents Chemother, 1978. Cited by 39 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Comparative susceptibilities of anaerobic bacteria to metronidazole, ornidazole, and SC-28538. Papers, record 718156. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/718156

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparative susceptibilities of anaerobic bacteria to metronidazole, ornidazole, and SC-28538.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1978
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
39
iCite
Relative citation ratio, by iCite
2.71
iCite
Revised in PubMed
2021-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Goldstein EJE J
2Sutter VLV L
3Finegold SMS M

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BacteriaMajor topic
MetronidazoleMajor topic
NitroimidazolesMajor topic
OrnidazoleMajor topic
Anaerobiosis
Microbial Sensitivity Tests

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
113627590[The activity of 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole (R. P. 8823) against experimental Trichomonas vaginalis infections].Ann Inst Pasteur (Paris)1959https://conductscience.org/library/papers/13627590PubMed
274641Bacteroides fragilis resistant to metronidazole after long-term therapy.Lancet1978https://conductscience.org/library/papers/74641PubMed
3412966Nitroimidazoles with antibacterial activity against Neisseria gonorrhoeae.J Med Chem1977https://conductscience.org/library/papers/412966PubMed
4321095Ornidazole: a new antiprotozoal compound for treatment of Trichomonas vaginalis infection.Br J Vener Dis1977https://conductscience.org/library/papers/321095PubMed
5922400Bacteriological study of otogenic cerebral abscesses: chemotherapeutic role of metronidazole.Br Med J1977https://conductscience.org/library/papers/922400PubMed
6896422[Treatment of meningitis caused by Bacteroides fragilis with injections of ornidazole].Nouv Presse Med1977https://conductscience.org/library/papers/896422PubMed
7856015Susceptibility of anaerobic bacteria to metronidazole, ornidazole, and tinidazole and routine susceptibility testing by standardized methods.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/856015PubMed
8984809Susceptibility of anaerobic bacteria to 23 antimicrobial agents.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/984809PubMed
91100592Treatment with metronidazole of three patients with serious infections due to Bacteroides fragilis.J Antimicrob Chemother1975https://conductscience.org/library/papers/1100592PubMed
104201423Synthesis of antimicrobial nitroimidazolyl 2-sulfides, -sulfoxides, and -sulfones.J Med Chem1973https://conductscience.org/library/papers/4201423PubMed
114496865Biochemical characterization and in vitro determination of antibiotic susceptibility of clinical isolates of Bacteroides fragilis.Scand J Infect Dis1974https://conductscience.org/library/papers/4496865PubMed
124635396Metronidazole versus anaerobes. In vitro data and initial clinical observations.Calif Med1972https://conductscience.org/library/papers/4635396PubMed
135038022Bactericidal activity of five antimicrobial agents against Bacteroides fragilis.J Infect Dis1972https://conductscience.org/library/papers/5038022PubMed
14961734A new approach to patients with suspected anaerobic postpartum pelvic infections. Transabdominal uterine aspiration for culture and metronidazole for treatment.Am J Obstet Gynecol1976https://conductscience.org/library/papers/961734PubMed
151253627Comparative pharmacokinetic studies of ornidazole and metronidazole in man.Chemotherapy1976https://conductscience.org/library/papers/1253627PubMed

Download CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMIDTitleJournalYearIn PapersSource
33515057Primary pituitary abscess in an adolescent female patient: case report, literature review, and operative video.Childs Nerv Syst2021https://conductscience.org/library/papers/33515057PubMed
28265816Efficacy and safety of morinidazole in pelvic inflammatory disease: results of a multicenter, double-blind, randomized trial.Eur J Clin Microbiol Infect Dis2017https://conductscience.org/library/papers/28265816PubMed
8781145Detection of anaerobic odontogenic infections by fluorine-18 fluoromisonidazole.Eur J Nucl Med1996https://conductscience.org/library/papers/8781145PubMed
7650197Experience with a novel selective medium for isolation of Actinomyces spp. from medical and dental specimens.J Clin Microbiol1995https://conductscience.org/library/papers/7650197PubMed
7325628Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/7325628PubMed
6742819Susceptibility of anaerobic bacteria from several French hospitals to three major antibiotics.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6742819PubMed
6305265Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6305265PubMed
6264842Susceptibility of anaerobic bacteria to nine antimicrobial agents and demonstration of decreased susceptibility of Clostridium perfringens to penicillin.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6264842PubMed
6100430Comparative in vitro activity of ceftriaxone against anaerobic bacteria.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6100430PubMed
4073879
Comparative evaluation of the 2-methyl-5-nitroimidazole compounds dimetridazole, metronidazole, secnidazole, ornidazole, tinidazole, carnidazole, and panidazole against Bacteroides fragilis and other bacteria of the Bacteroides fragilis group.
Antimicrob Agents Chemother1985https://conductscience.org/library/papers/4073879PubMed
3986079Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis.Br J Clin Pharmacol1985https://conductscience.org/library/papers/3986079PubMed
3121339Studies on the disposition of a 5-nitroimidazole in laboratory animals.Eur J Drug Metab Pharmacokinet1987https://conductscience.org/library/papers/3121339PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/718156

GET https://conductscience.org/api/papers/v1/718156/authors